Researcher
Wim Mulders
Affiliations
- Mycobacteriology (Research unit)
Member
From17 Sep 2007 → Today - Mycobacteriology (Research unit)
Member
From31 Dec 2014 → 16 Apr 2015 - Mycobacteriology (Research unit)
Member
From28 Feb 2014 → 16 Jan 2015 - Mycobacteriology (Research unit)
Member
From31 Oct 2013 → 7 Mar 2014 - Mycobacteriology (Research unit)
Member
From30 Sep 2010 → 13 Nov 2013
Publications
1 - 10 of 14
- Refined understanding of the impact of the Mycobacterium tuberculosis complex diversity on the intrinsic susceptibility to pretomanid(2024)
Authors: Rupasinghe Arachchige Praharshinie Rupasinghe, Rabab Reenaers, Jens Vereecken, Leen Rigouts, W Mulders, Stefan Niemann, Matthias Merker, Claudio U. Koeser, Sari Cogneau, Shaheed Vally Omar, et al.
- Rifampicin resistance conferring mutations among Mycobacterium tuberculosis strains in Rwanda(2023)
Authors: Isabel Cuella Martin, Jean Claude Semuto Ngabonziza, Gabriela Torrea, Conor J. Meehan, W Mulders, Bertin Ushizimpumu, Louise De Weerdt, Jelle Keysers, Willem Bram de Rijk, T Decroo, et al.
Pages: 274-281 - Bedaquiline- and clofazimine- selected Mycobacterium tuberculosis mutants: further insights on resistance driven largely by Rv0678(2023)
Authors: Jihad Snobre, M C Villellas, Nele Coeck, W Mulders, Oren Tzfadia, Bouke de Jong, K Andries, Leen Rigouts
- Multidrug-resistant tuberculosis control in Rwanda overcomes a successful clone that causes most disease over a quarter century(2022)
Authors: Jean Claude Semuto Ngabonziza, Leen Rigouts, Gabriela Torrea, T Decroo, Eliane Kamanzi, Pauline Lempens, Aniceth Rucogoza, Yves Mucyo Habimana, Lies Laenen, Esdras Belamo Niyigena, et al.
- Finding the right balance between efficacy and tolerability for TB treatment: the search continues(2021)
Authors: A.K.J. Maug, M.A. Hossain, M Gumusboga, T Decroo, W Mulders, Sofie Braet, Jozefien Buyze, D A Jiménez, Céline Schurmans, Natacha Herssens, et al.
Pages: 84-86 - Effectiveness of GenoType MTBDRsl in excluding TB drug resistance in a clinical trial(2021)
Authors: Mebrat Ejo Kitata, Armand Van Deun, A Nunn, SEO Meredith, S. Ahmed, D. Dalai, O. Tumenbayar, B. Tsogt, P. T. Dat, D. T. M. Ha, et al.
Pages: 839-845 - First-line tuberculosis treatment with double-dose rifampicin is well tolerated(2020)
Authors: A.K.J. Maug, M.A. Hossain, M Gumusboga, T Decroo, W Mulders, Sofie Braet, Jozefien Buyze, Diana Arango, Céline Schurmans, Natacha Herssens, et al.
Pages: 499-505 - Case report: dynamics of acquired fluoroquinolone resistance under standardized short-course treatment of multidrug-resistant tuberculosis(2020)
Authors: Jean Claude Semuto Ngabonziza, Armand Van Deun, Patrick Migambi, Niyigena Esdras Belamo, Dusabe Théogène, Yves Mucyo Habimana, Bertin Ushizimpumu, W Mulders, T Decroo, Dissou Affolabi, et al.
Pages: 1443-1446 - The perceived impact of isoniazid resistance on outcome of first-line rifampicin-throughout regimens is largely due to missed rifampicin resistance(2020)
Authors: Armand Van Deun, T Decroo, Aung Kya Jai Maug, Mohamed Anwar Hossain, Murid Gumusboga, W Mulders, Nimer Ortuno-Gutierrez, L Lynen, Bouke de Jong, Hans L. Rieder
- A sister lineage of the Mycobacterium tuberculosis complex discovered in the African Great Lakes region(2020)
Authors: Jean Claude Semuto Ngabonziza, Chloe Loiseau, Michael Marceau, Agathe Jouet, Fabrizio Menardo, Oren Tzfadia, Rudy Antoine, Esdras Belamo Niyigena, W Mulders, K Fissette, et al.